InvestorsHub Logo
Followers 6
Posts 615
Boards Moderated 0
Alias Born 06/01/2015

Re: None

Tuesday, 04/18/2017 3:19:12 PM

Tuesday, April 18, 2017 3:19:12 PM

Post# of 1874
Last year Celgene "[backed] next-gen oncolytic virus startup," Oncorus, a privately held company. Currently, Celgene has entered into a "First-in-Class Collaboration," with Oncolytics. Very interesting.

From Oncorus' website:

"Celgene backs next-gen oncolytic virus startup in $57M Series A
"Newly unveiled Oncorus has raised a $57 million Series A to back its efforts to use next-gen oncolytic viruses to treat aggressive cancers including a type of brain cancer, glioblastoma multiforme (GBM). Active strategic investor Celgene ($CELG) participated in the financing, which was led by MPM Capital."

Read the article from FierceBiotech"

http://www.fiercebiotech.com/biotech/celgene-backs-next-gen-oncolytic-virus-startup-57m-series-a

https://www.oncolyticsbiotech.com/news/oncolytics-biotech-inc-enters-into-first-in-class-collaboration-with-myeloma-uk-and-celgene-using-reolysin-in-combination-with-imnovid-or-revlimid-in-patients-with-myeloma/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCY News